Evidence map›Paper›PMID 35177990›Full record

ArticleFrontiers in pharmacology2022

Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study.

Haitao Wang, Haitao Shi, Yan Wang, Na Wang, Youjia Li, Qianting Yang, Ya Li, Chenwei Liu, Ying Zan, Siping Feng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Haitao WangDepartment of Pharmacy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Haitao ShiDepartment of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yan WangDepartment of Pharmacy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Na WangDepartment of Pharmacy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Youjia LiDepartment of Pharmacy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Qianting YangDepartment of Pharmacy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ya LiDepartment of Pharmacy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Chenwei LiuDepartment of Pharmacy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ying ZanDepartment of Medical Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Siping FengDepartment of Pharmacy, Yan'an People's Hospital, Yan'an, China.
Jiao XieDepartment of Pharmacy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Second Affiliated Hospital of Xi'an Jiaotong University · CNYan'an University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse drug events (ADE)cancerdrug-drug interaction (DDI)oral antineoplastic agentsprevalence

Identifiers

PMID35177990
PMCPMC8844504
OpenAlexW4210509989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.